IMMUNITYBIO INC (IBRX) Stock Cash Flow
NASDAQ:IBRX - Nasdaq - US45256X1037 - Common Stock - Currency: USD
| TTM (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -409.18M | -413.64M | -583.85M | -417.32M | -349.85M | |||
| Depreciation Amortization | 16.83M | 17.55M | 18.51M | 18.26M | 14.24M | |||
| Income Taxes - Deferred | N/A | N/A | N/A | 0.00 | -10.00K | |||
| Change In Working Capital | -37.56M | -19.42M | 3.98M | -8.00M | -19.11M | |||
| Interest Paid | 84.00M | 92.32M | 77.19M | 35.44M | 2.11M | |||
| Taxes Paid | 7.00K | 15.00K | 8.00K | 0.00 | 10.00K | |||
| Other non cash items | 59.76M | 24.28M | 194.61M | 69.56M | 80.31M | |||
| OPERATING CASH FLOW | -370.16M | -391.24M | -366.76M | -337.51M | -274.42M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -6.75M | -6.89M | -30.58M | -99.39M | -33.56M | |||
| Other Investing Activity | 34.25M | -5.36M | 114.00K | 126.69M | -51.32M | |||
| INVESTING CASH FLOW | 27.50M | -12.25M | -30.47M | 27.30M | -84.89M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | 96.92M | 96.89M | 451.39M | 174.13M | 338.50M | |||
| Stock Issued/Repurchased | 173.51M | 184.74M | 106.95M | 59.89M | 165.93M | |||
| Other Financing Activity | N/A | 0.00 | 0.00 | -400.00K | 1.02M | |||
| FINANCING CASH FLOW | 270.42M | 281.63M | 558.34M | 233.61M | 505.44M | |||
| Exchange Rate Effect | 6.00K | -23.00K | -292.00K | 280.00K | 50.00K | |||
| CHANGE IN CASH | -72.22M | -121.88M | 160.82M | -76.32M | 146.18M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -370.16M | -391.24M | -366.76M | -337.51M | -274.42M | |||
| Capital Expenditure | -6.75M | -6.89M | -30.58M | -99.39M | -33.56M | |||
| FREE CASH FLOW | -376.91M | -398.12M | -397.34M | -436.90M | -307.98M | |||
All data in USD